Exhibit 99.2

 

ASX ANNOUNCEMENT 20 NOVEMBER 2025 Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889 Results of Annual General Meeting Sydney, Australia – 20 November 2025 – Radiopharm Theranostics (ASX:RAD) advises that all resolutions considered at the Annual General Meeting held today were carried by poll. In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached. As more than 75% of votes received were cast in favour of Resolution 1, Resolution 10 was withdrawn. Further to the announcement on 19 November 2025 regarding the appointment of Mr Bruce Goodwin as a Non - Executive Director, the Company confirms the re - appointment of Mr Bruce Goodwin as a Non - Executive Director under section 201H(1) of the Corporations Act 2001 following the end of the Annual General Meeting. Phillip Hains Joint Company Secretary

 

 

Disclosure of Proxy Votes Radiopharm Theranostics Limited Annual General Meeting Thursday, 20 November 2025 In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutio ns put to members at the meeting. Automic GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 Proxy Votes Poll Results (if applicable) Results Resolution Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed FOR AGAINST ABSTAIN PROXY'S DISCRETION FOR AGAINST ABSTAIN OUTCOME S250U APPLICABLE 1 Remuneration Report P 1,084,096,640 911,862,142 84.11% 172,036,162 15.87% 29,396,870 198,336 0.02% 912,142,333 84.13% 172,036,162 15.87% 2 Re - election of Director – Mr Paul Hopper P 1,109,857,736 935,063,731 84.25% 174,695,669 15.74% 162,110,786 98,336 0.01% 935,243,922 84.26% 174,695,669 15.74% 162,110,786 Carried n/a 3 Re - election of Director – Ms Hester Larkin P 1,271,570,902 1,107,334,584 87.08% 164,037,982 12.90% 397,620 198,336 0.02% 1,107,614,775 87.10% 164,037,982 12.90% 397,620 Carried n/a 4 Ratification of prior issue of Placement Shares to Lantheus P 987,926,986 976,340,262 98.83% 11,488,388 1.16% 1,083,023 98,336 0.01% 976,520,453 98.84% 11,488,388 1.16% 1,083,023 Carried n/a 5 Approval to issue Equity Securities under Omnibus Incentive Plan P 1,084,572,755 904,596,999 83.41% 179,920,185 16.59% 187,395,767 55,571 0.01% 904,734,425 83.41% 179,920,185 16.59% 187,395,767 Carried n/a 6 Approval to issue Incentive Options to Director – Mr Paul Hopper P 1,084,862,909 904,454,681 83.37% 180,352,657 16.62% 93,534,185 55,571 0.01% 904,592,107 83.38% 180,352,657 16.62% 93,534,185 Carried n/a 7 Approval to issue Incentive Options to Director – Mr Riccardo Canevari P 1,084,862,909 1,012,916,596 93.37% 71,790,742 6.62% 187,105,613 155,571 0.01% 1,013,154,022 93.38% 71,790,742 6.62% 187,105,613 Carried n/a 8 Approval to issue Incentive Options to Director – Mr Ian Turner P 1,084,812,909 914,247,461 84.28% 170,409,877 15.71% 187,155,613 155,571 0.01% 914,484,887 84.29% 170,409,877 15.71% 187,155,613 Carried n/a 29,396,870 Carried No

 

 

Proxy Votes Poll Results (if applicable) Results Resolution Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed FOR AGAINST ABSTAIN PROXY'S DISCRETION FOR AGAINST ABSTAIN OUTCOME S250U APPLICABLE 9 Approval of 10% capacity under Listing Rule 7.1A P 1,228,497,414 1,160,228,155 94.44% 68,113,688 5.54% 43,471,108 155,571 0.01% 1,160,465,581 94.46% 68,113,688 5.54% 43,471,108 Carried n/a 10 Contingent business - Board Spill Meeting (conditional item) If less than 25% of the votes cast on Resolution 1 are voted against adoption of the Remuneration Report, the Chair will withdraw Resolution 10. IMPORTANT - The Board strongly recommends you vote against Resolution 10. - 1,112,253,075 264,532,620 23.78% 847,664,884 76.21% 1,240,435 55,571 0.00% Resolution withdrawn - n/a